Background
Determining immunologic correlates that may be associated with virologic suppression while on alternate or curative HIV therapy is a priority for children. We longitudinally investigated immune responses among participants in the Tatelo Study with and without virologic failure during 6 months of dual bNAb-treatment after ART interruption.
Methods
Using multiparametric spectral flow cytometry we analyzed innate and adaptive immune cell populations at two time points: 1) the start of bNAb-only treatment and 2) at ART reinitiation after six months or upon viral rebound. We correlated immunological findings with viral reservoir characteristics obtained through FLIP-seq and MIP-seq.
Results
Of 25 participants aged 2-5 years who received VRC01LS plus 10-1074 dual-bNAb treatment, 11 maintained viral suppression (controllers) and 14 rebounded (rebounders). Controllers exhibited a trend toward higher proportion of CD56dimCD16dim NK cells and lower proportion of CD56posCD16– NK cells compared to rebounders, at both time points. The percentage of NK cells expressing the inhibitory receptor KIR2DL1 tended to be higher in rebounders at the start of bNAb-only-treatment (p=0.09) and at ART reinitiation (p=0.04). This was also true for the subset of KIR2DL1+NKG2A–NKp46–NKp30– NK cells at the start of bNAb-only-treatment (p=0.05). Additionally, the proportion of cells expressing KIR2DL1 positively correlated with the frequency of intact proviruses (p= 0.008) and with a shorter time to rebound (p=0.01). The higher expression of KIR2DL1 in rebounders was paired with an enrichment of HLA-C allotypes (p=0.03) that display elevated surface expression and serve as preferred inhibitory ligands for KIR2DL1. The proportions of NKG2A-expressing NK cells at the start of bNAb-only-treatment were positively correlated with time to rebound (p=0.012) and inversely correlated with intact reservoir size at both time points (p=0.014). Frequencies of HIV-1-specific T cells were low at both time points, did not differ between controllers and rebounders, and did not correlate with viral reservoir size.
Conclusions
Specific NK cell responses at the beginning of bNAb-only treatment were associated with viral rebound, the kinetics of rebound, and the intact viral reservoir size. HIV-1 specific T cell responses were low in this group of early-treated children and differences could not be identified between controllers and rebounders.